AbbVie has been reporting an earnings decline because its former lead drug, Humira, lost patent-protected market exclusivity ...

One chief equity strategist says that the S&P 500 Index could face a significant decline next year following its 2024 gains.

The S&P 500 advanced 0.8% on Monday, adding to the benchmark index's all-time high Friday for a second straight record close.

The S&P 500 index was up slightly Wednesday, with sector gains led by utilities and financials, according to FactSet data, at last check. The utilities sector was up 1.1% Wednesday morning, while the ...

Short interest for healthcare stocks in S&P 500 increased during September end vs. last month, with Moderna being most ...

UBS Global Research on Tuesday raised its year-end target for the benchmark S&P 500 index to 5,850 points from an earlier ...

Investing in an S&P 500 index fund can let you take a set-it-and-forget-it approach. But some experts say you could be ...

Charles Schwab ( SCHW) shares jumped 6.1% after the brokerage firm posted its results for the third quarter, exceeding ...

In fact, the S&P 500 just generated its best January-through-September returns since 1997. History suggests there's more to ...

MicroStrategy stock has outperformed all S&P 500 firms since 2020, but despite its robust performance, a listing in the index ...

Stock futures were pretty much flat on Monday as investors braced themselves for the first full week of third-quarter ...

But for many investors, S&P 500 index funds remain the overwhelming favorite when it comes to long-term investing. The S&P 500 index tracks the prices of the 500 largest U.S. public companies ...